658.06
Idexx Laboratories Inc stock is traded at $658.06, with a volume of 566.23K.
It is up +1.23% in the last 24 hours and up +22.13% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$650.06
Open:
$651.6
24h Volume:
566.23K
Relative Volume:
0.92
Market Cap:
$52.92B
Revenue:
$4.04B
Net Income/Loss:
$985.66M
P/E Ratio:
54.79
EPS:
12.01
Net Cash Flow:
$774.34M
1W Performance:
+22.88%
1M Performance:
+22.13%
6M Performance:
+43.12%
1Y Performance:
+35.99%
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-05-25 | Reiterated | BTIG Research | Buy |
Jul-01-25 | Initiated | Jefferies | Buy |
Dec-02-24 | Initiated | Leerink Partners | Outperform |
Jul-25-24 | Initiated | BTIG Research | Buy |
Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
Jul-25-22 | Downgrade | Stifel | Buy → Hold |
Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
Jul-12-22 | Initiated | Piper Sandler | Overweight |
May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
Feb-08-22 | Initiated | Atlantic Equities | Overweight |
Nov-18-21 | Initiated | Morgan Stanley | Overweight |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
Feb-17-21 | Initiated | Barclays | Overweight |
Sep-09-19 | Initiated | Goldman | Neutral |
May-23-19 | Initiated | Guggenheim | Buy |
Nov-02-18 | Reiterated | BofA/Merrill | Buy |
May-07-18 | Reiterated | Stifel | Buy |
Jan-16-18 | Initiated | Piper Jaffray | Overweight |
Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
Jul-28-17 | Upgrade | CL King | Neutral → Buy |
Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
Sep-29-16 | Resumed | BofA/Merrill | Neutral |
Aug-16-16 | Reiterated | Stifel | Buy |
Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
Apr-01-16 | Initiated | CL King | Neutral |
Mar-21-16 | Reiterated | Stifel | Buy |
Feb-04-16 | Initiated | Credit Suisse | Outperform |
Oct-29-15 | Reiterated | Stifel | Buy |
Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
Aug-13-15 | Reiterated | Stifel | Buy |
Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
IDEXX Labs Volume Plummets 28% as Veterinary Diagnostics Stock Slides to 256th in U.S. Trading Activity Rankings - AInvest
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $675.00 at JPMorgan Chase & Co. - MarketBeat
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - au.finance.yahoo.com
How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs - MSN
IDEXX’s Healthy Streak Outpaces The Pack In Animal Care - Finimize
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $745 - 富途牛牛
Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2025 Earnings Call Transcript - Insider Monkey
Why a Company You’ve Never Heard of Is One of the Best Nasdaq-100 Stocks of the Year - inkl
IDEXX strengthens competitive edge in veterinary diagnostics - MarketScreener
IDEXX Laboratories stock price target raised to $785 from $625 at Jefferies - Investing.com India
Idexx Laboratories: Strong Financial Performance and Strategic Outlook Justify Buy Rating - TipRanks
IDEXX Executives Make Major Stock Trades on August 6 - AInvest
IDEXX Laboratories Reports Strong Q2 2025 Results - The Globe and Mail
IDEXX Laboratories’ Earnings Call Highlights Strong Growth - TipRanks
Is the Market Bullish or Bearish on IDEXX Laboratories? - 富途牛牛
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $626 to $785 - 富途牛牛
Jefferies Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $785 - 富途牛牛
Tesla, Delta Air, IDEXX Laboratories And More On CNBC's 'Final Trades' - Benzinga
BNP Paribas Exane Adjusts PT on IDEXX Laboratories to $761 From $577, Maintains Outperform Rating - MarketScreener
Morgan Stanley Adjusts PT on IDEXX Laboratories to $722 From $626, Maintains Overweight Rating - MarketScreener
IDXX Surpasses Analyst Target Price of $558.30 - AInvest
Axon Enterprise, Berkshire Hathaway, Idexx Laboratories - TradingView
IDEXX Laboratories Inc (IDXX) Q2 2025 Earnings Call Highlights: Strong Revenue and EPS Growth ... - Yahoo Finance
IDEXX Laboratories Stock Price, Quotes and Forecasts | NASDAQ:IDXX - Benzinga
Idexx: Q2 Earnings Snapshot - Norwalk Hour
IDEXX Laboratories Inc (IDXX) Q2 2025 Earnings Call Highlights: Strong Revenue and EPS Growth ... By GuruFocus - Investing.com Canada
IDEXX Laboratories Soars: A New Benchmark for Animal Health Diagnostics - FinancialContent
IDEXX Laboratories' Price Target Raised to $675 by JP Morgan, Maintains Overweight Rating - AInvest
JPMorgan Boosts Idexx Laboratories' Price Target to $675, Maintains Overweight Rating - AInvest
BofA Boosts Price Target for Idexx Laboratories to $700 Amid Robust Q2 Performance - AInvest
IDEXX Laboratories Surges on Raised Revenue and Profit Forecasts, Analysts Mixed on One-Year Price Target - AInvest
Stifel Raises Idexx Laboratories Price Target to $640, Keeps Hold Rating - AInvest
Research Alert: CFRA Maintains Buy Opinion On Shares Of Idexx Laboratories, Inc. - 富途牛牛
IDEXX Laboratories Surges on Price Target Adjustments and New Board Member - timothysykes.com
Log Commercial 2Q net revenue R$61.5M, estimate R$60.3M - AInvest
IDEXX Labs Stock Sparks Interest: Analyzing Market Buzz - timothysykes.com
IDEXX LABORATORIES INC /DE SEC 10-Q Report - TradingView
U.S. Indexes Moved Upward Monday; IDEXX Laboratories Led Increases - Barron's
How A 'Puppy Boom' Drove This Company's Beat-And-Raise - Investor's Business Daily
IDEXX Laboratories Stock: Ready for a Breakout? - StocksToTrade
Idexx's Innovation Is on Display with Introduction of InVue Platform - Morningstar
IDEXX Laboratories (IDXX) Boosts 2025 Earnings and Revenue Forecasts - GuruFocus
Is Now a Good Time to Reenter IDEXX Laboratories Inc.Low Risk High Return Opportunities Identified - metal.it
IDEXX Surge: Time to Dive In? - timothysykes.com
Palantir, IDEXX Lead Market Cap Stock Movers on Monday - Investing.com
Idexx Laboratories Shares Rise After 2Q Earnings, Revenue Beat Expectations - 富途牛牛
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):